Table 3 The LV myocardial native T1, T2 mapping, and ECV valued in benign and primary malignant cardiac tumors in different locations
From: Multiparametric mapping by cardiovascular magnetic resonance imaging in cardiac tumors
| Â | LA | RA | LV | RV | Valves |
|---|---|---|---|---|---|
Benign | |||||
 T1 mapping-mean (ms) | 1287 ± 54 | 1269 ± 40 | 1239 ± 35 | 1254 ± 26 | 1197 ± 101 |
 T2 mapping-mean (ms) | 41 ± 4.0 | 42 ± 2.8 | 40 ± 2.2 | 40 ± 3.5 | 39 ± 4.3 |
 ECV-mean | 30 ± 2.3 | 32 ± 5.4 | 30 ± 2.8 | 29 ± 2.4 | 30 ± 4.0 |
Primary malignant | |||||
 T1 mapping-mean (ms) | 1330 ± 14* | 1379 ± 50* | 1357 ± 36* | 1376 ± 69* | 1186 |
 T2 mapping-mean (ms) | 43 ± 5.4 | 41 ± 2.2 | 40 ± 4.7 | 44 ± 3.2 | 35 |
 ECV-mean (%) | 35 ± 2.3* | 34 ± 5.1* | 38 ± 7.5* | 37 ± 6.0* | 25 |